Collaboration specifics between Adisyn and 2D Generation Adisyn (ASX: AI1) recently revealed a binding collaboration agreement with 2D Generation, a leading global semiconductor developer. The Israel-based company intends to utilize Adisyn’s proficiency in data center management, managed IT services, and cybersecurity, in conjunction with its own top-tier expertise in creating cutting-edge artificial intelligence (AI) semiconductor solutions.

A new drilling permit has been issued for the Nemaha project. HyTerra, a firm focused on the exploration of white hydrogen and helium, has received a fresh drilling permit for its Nemaha project in Kansas. The Kansas Corporation Commission has authorized HyTerra’s subsidiary, HYT Operating, to drill the Blythe 13-20 well at Nemaha.

Reorganization of the board and executive team RareX (ASX: REE) has implemented a major reorganization of its board and management team to speed up exploration efforts at its recently acquired Khaleesi project located in the East Yilgarn area of Western Australia.

iTech Minerals obtains $1.25 million via the JMEI initiative. iTech Minerals (ASX: ITM) has recently disclosed that it will obtain $1.25 million from the Australian Taxation Office via the Junior Minerals Exploration Incentive (JMEI) initiative. This program permits qualifying exploration companies to create refundable tax credits, which can be allocated to eligible investors as tax offsets.

Barton Gold secures maximum JMEI credits Barton Gold (ASX: BGD) (OTCQB: BGDFF) has officially announced that it has been granted ,488,500 in credits from the Australian Taxation Office (ATO). The company has successfully received the maximum Junior Minerals Exploration Incentive (JMEI) credits that it had applied for, which are specifically related to the 2024/25 financial year.

Monepantel’s inclusion in HEALEY ALS trial PharmAust’s lead treatment candidate for amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), Monepantel (MPL), has been selected to participate in the prestigious HEALEY ALS Phase 2/3 platform trial. This inclusion marks a significant milestone for PharmAust, as the HEALEY ALS trial is renowned for its rigorous standards and comprehensive approach to evaluating potential treatments for ALS/MND.

Most punctual U.S. airlines Based on data collected by the U.S. Department of Transportation during the first quarter of 2024, these are the three major American airlines whose flights arrive as scheduled most often: Delta is by far the most punctual American airline, with an on-time rate almost four percentage points higher than its nearest competitor.

Tesla’s robotaxi delay Elon Musk’s vision for his EV automaker, Tesla (TSLA), of being “more of an AI and robotics company” has hit a significant roadblock, as a major component of its anticipated future business won’t see the eyes of the public for much longer.